KYPROLIS (carfilzomib)
Onyx pharms amgen
Patent: 8,129,346
Expiration: Apr 14, 2025
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com